Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/01/1992 | WO1992016552A1 1-imidazolgemethyl benzofuran derivatives as inhibitors of angiotensin ii activity |
10/01/1992 | WO1992016524A1 Benzo-fused lactams promote release of growth hormone |
10/01/1992 | WO1992016521A1 Novel fluorine-containing quinolones and process for their preparation |
10/01/1992 | WO1992016517A1 Pharmaceutical xanthone derivatives |
10/01/1992 | WO1992016503A1 New sulphonamides, process for preparing the same and medicaments containing these compounds |
10/01/1992 | WO1992016496A1 N-[[4,5-dihydroxy- and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracene-yl]carbonyl]amino acids useful in the therapy of osteoarticular affections |
10/01/1992 | WO1992016484A1 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
10/01/1992 | WO1992016239A1 Radiopharmaceutical agents for the detection of alzheimer's disease |
10/01/1992 | WO1992016233A1 Pharmaceutical combination for the treatment of prostatic cancer containing a 5 alpha reductase inhibitor and an antiandrogen |
10/01/1992 | WO1992016229A1 Products containing verapamil and trandolapril |
10/01/1992 | WO1992016226A1 Il-1 inhibitors |
10/01/1992 | WO1992016217A1 Sexual tonic for men |
10/01/1992 | WO1992016215A1 Use of 3'-azido-2',3'-dideoxyguanosine for the treatment of hepatitis b |
10/01/1992 | WO1992016214A1 The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d) |
10/01/1992 | WO1992016213A1 Pharmaceutical combination for the treatment of prostatic hyperplasia, containing a 5 alpha-reductase inhibitor and an antiandrogen |
10/01/1992 | WO1992016212A1 Increasing the therapeutic efficiency of macrophage-targeted therapeutic agents by up-regulating the mannose lectin on macrophages |
10/01/1992 | WO1992016211A1 New use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disorders |
10/01/1992 | WO1992016210A1 Novel liquid compositions based on derivatives of 1,4 substituted piperidine |
10/01/1992 | WO1992016209A1 Granules and veterinary compositions comprising a water-soluble complex of flumequine |
10/01/1992 | WO1992016208A1 Use of benzimidazole anthelmintic in the treatment of microsporidial infections |
10/01/1992 | WO1992016206A1 The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d) |
10/01/1992 | WO1992016204A1 Method of reducing serum levels of lipoprotein(a) |
10/01/1992 | WO1992016203A1 Palytoxin-related prodrugs and a method for their administration |
10/01/1992 | WO1992016202A1 Percutaneous anaesthesia |
10/01/1992 | WO1992016201A1 Method for inactivating enveloped viruses and sperm |
10/01/1992 | WO1992016200A1 The use of hydroxamic acid derivatives to inhibit viral replication |
10/01/1992 | WO1992016199A1 Method and products for treating the eye |
10/01/1992 | WO1992016198A2 Method and products for treating the eye |
10/01/1992 | WO1992016189A1 Soluble melanin |
10/01/1992 | WO1992016181A2 Composition for promoting tissue repair and regeneration |
10/01/1992 | WO1992016173A1 Methods and compositions for treating pulmonary disorders using optically pure terbutaline |
10/01/1992 | WO1992016104A1 Leukotriene antagonists |
10/01/1992 | WO1992009281A3 Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia |
10/01/1992 | WO1992004048A3 Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies |
10/01/1992 | DE4110409A1 Neue protein-polykation-konjugate New protein-polycation conjugates |
10/01/1992 | DE4110087A1 Benfotiamine-contg. pharmaceutical for topical use - is for treating e.g. rheumatic disorders, sciatica, lumbago, migraine etc. and other disorders beneficially affected by vitamin=B |
10/01/1992 | DE4109735A1 Neue sulfonamide, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten New sulfonamides, process for their production and pharmaceuticals containing these compounds |
10/01/1992 | CA2106772A1 New sulphonamides, processes for their preparation and medicaments containing these compounds |
10/01/1992 | CA2103787A1 Use of benzimidazole anthelmintic in the treatment of microsporidial infections |
10/01/1992 | CA2092205A1 Soluble melanin |
09/30/1992 | WO1992017188A1 New non-anticoagulant heparin derivatives |
09/30/1992 | WO1992017187A1 New non-anticoagulant heparin derivatives |
09/30/1992 | WO1992017185A1 Targeted drug delivery via mixed phosphate derivatives |
09/30/1992 | WO1992017181A1 Pharmaceutical compositions and methods for preventing skin tumor formation and causing regression of existing tumors |
09/30/1992 | WO1992017077A2 Fat substitute compositions having reduced laxative effects |
09/30/1992 | EP0506628A2 Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances |
09/30/1992 | EP0506565A1 Use of 4,9,11-trienic steroids in compositions for turkeys |
09/30/1992 | EP0506545A2 Use of 4-amino-1-(2-pyridyl)piperidines as 5-HT3-agonists for the treatment and prophylaxis of serotoninergic dysfunctions |
09/30/1992 | EP0506539A1 Heterocyclic alkylamides, process for their preparation and pharmaceutical compositions containing them |
09/30/1992 | EP0506532A1 Indole derivatives, process for their preparation and medicaments containing them |
09/30/1992 | EP0506478A1 Piperidine derivatives |
09/30/1992 | EP0506468A1 N-substituted 4-phenyl-piperidine opioid-antagonists |
09/30/1992 | EP0506463A2 New compounds, named the "leustroducsins" their preparation and their therapeutic uses |
09/30/1992 | EP0506434A1 Thiazolidinone and oxazolidinone derivatives, their preparation and their use as vasodilators |
09/30/1992 | EP0506388A1 1-Hydroxyvitamin D derivatives |
09/30/1992 | EP0506384A1 Pharmaceutical composition for the treatment of urinary incontinence containing DL- or L-threo-3-(3,4-dihydroxyphenyl)serine |
09/30/1992 | EP0506369A1 6-Heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[CD]indoles |
09/30/1992 | EP0506363A1 6-Heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd]indoles |
09/30/1992 | EP0506331A1 4"-and 4'-alkylthio-avermectin derivatives |
09/30/1992 | EP0506326A2 Diequitorially bound beta 1-4 polyuronates and use of same for cytokine stimulation |
09/30/1992 | EP0506325A1 Guluronic acid polymers and use of same for inhibition of cytokine production |
09/30/1992 | EP0506300A2 Tacky, hydrophilic gel dressings and products therefrom |
09/30/1992 | EP0506207A2 Pharmaceutical vehicles for reducing transdermal flux |
09/30/1992 | EP0506205A1 Use of adenosine for the manufacture of medicaments for continuous intravenous infusion to human patients |
09/30/1992 | EP0506197A1 Topical preparation containing a suspension of solid lipid particles |
09/30/1992 | EP0506194A1 4-aryl-thiazole or imidazole derivatives |
09/30/1992 | EP0506166A2 Ingestible material |
09/30/1992 | EP0506072A1 Novel azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis |
09/30/1992 | EP0506048A1 Sulfated tocopheryl oligosaccharides and antiviral agents including the same as active ingredients |
09/30/1992 | EP0506011A1 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity |
09/30/1992 | EP0506008A1 Bis-naphthalimides containing amino-acid derived linkers as anticancer agents |
09/30/1992 | EP0505954A1 N-Imidazolylmethyl benzofuran derivatives as inhibitors of angiotensin II activity |
09/30/1992 | EP0505923A1 Phenol ethers, process for their preparation and medicaments containing them |
09/30/1992 | EP0505901A2 Use of 1-phenoxycarbonyl-2-pyrralidinone derivatives for treating or preventing platelet aggregation |
09/30/1992 | EP0505893A1 Imidazopyridines |
09/30/1992 | EP0505872A1 Swallable tablet with a high content of edible organic acid salts |
09/30/1992 | EP0505868A2 N-Acyl-alpha-aminoacids derivatives |
09/30/1992 | EP0505841A2 Analgesic composition containing beta-carotene |
09/30/1992 | EP0505817A1 Use of phosphatidylserine and its derivatives for the manufacture of a medicament for the treatment of degenerative pathologies also associated with immune disfunctions |
09/30/1992 | EP0505778A1 Derivatives of substituted imidazol-2-one and process for their preparation |
09/30/1992 | EP0505640A1 Improved therapeutic method |
09/30/1992 | EP0505608A2 Alpha-dihydroergocryptine pharmaceutical preparations with neuroprotective acitivity |
09/30/1992 | EP0505543A1 NOVEL p-SUBSTITUTED PHENYL 4-OXYBUTANE AMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
09/30/1992 | EP0505487A1 Growth arrest of proliferating cells by transglutaminase inhibitors |
09/30/1992 | EP0505481A1 2-substituted 4,5-diphenyl-imidazoles |
09/30/1992 | EP0505467A1 Pharmacologically active amide carboxylate derivatives |
09/30/1992 | EP0505454A1 Container for fan-folded sheets. |
09/30/1992 | EP0505434A1 Heterocyclic substituted naphthyridinones and methods and compositions employing them |
09/30/1992 | EP0505400A1 N-substituted naphthalamides, their production and use |
09/30/1992 | EP0505374A1 Vitamin-mineral treatment methods and compositions. |
09/30/1992 | CN1064869A Separation-extraction technology of cyclovirobuxine and its pills |
09/30/1992 | CN1064865A 4-((2-benzothiazolyl) methylamino)-alpha-((3,4-difluorophinoxy) methyl)-1-piperidineethanol |
09/30/1992 | CN1064864A Substituted tetralins and process for preparing related compounds |
09/30/1992 | CN1064863A Pharmaceutical preparation containing functional vinyl pyrrole, use thereof in preparing medicine, vinyl pyrrole self and process for preparing them |
09/30/1992 | CN1064861A Polyhydroxycyclopentane derivatives, their preparation and their therapeutic use |
09/30/1992 | CN1064810A Low dose dry pharmaceutical preparations |
09/30/1992 | CN1064808A Efficient growth promoting agent for animal |
09/30/1992 | CN1064807A Method for producing pharmaceutical composite containing alkylmelatonins |
09/30/1992 | CN1018456B B-halomilbemycin derivatives, their preparation and compositions containing them |
09/30/1992 | CN1018454B Benzamides, method of obtaining them and therapeutic applications |